The cost-effectiveness of radiofrequency ablation for treating patients with gastric antral vascular ectasia refractory to first line endoscopic therapy

References

• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. 2017.
   Google Scholar
• Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87(5):1165–1170.
   PubMed Web of Science ®Google Scholar
• Dulai GS, Jensen DM, Kovacs TO, et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy. 2004;36(1):68–72.
   PubMed Web of Science ®Google Scholar
• Ward EM, Raimondo M, Rosser BG, et al. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol. 2004;38(10):898–900.
   PubMed Web of Science ®Google Scholar
• Marie I, Ducrotte P, Antonietti M, et al. Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther. 2008;28(4):412–421.
   PubMed Web of Science ®Google Scholar
• Gretz JE, Achem SR. The watermelon stomach: clinical presentation, diagnosis, and treatment. Am J Gastroenterology. 1998;93(6):890–895.
   PubMed Web of Science ®Google Scholar
• Novitsky YW, Kercher KW, Czerniach DR, et al. Watermelon stomach: pathophysiology, diagnosis, and management. J Gastrointest Surg. 2003;7(5):652–661.
   PubMed Web of Science ®Google Scholar
• Selinger CP, Ang YS. Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment. Digestion. 2008;77(2):131–137.
   PubMed Web of Science ®Google Scholar
• Oge T, Kilic CH, Kilic GS. Economic impact of blood transfusions: balancing cost and benefits. EAJM. 2014;46(1):47–49.
   Google Scholar
• Stokes EA, Wordsworth S, Staves J, et al. Accurate costs of blood. Transfusion. 2018;58(4):846–853.
   PubMed Web of Science ®Google Scholar
• Fuccio L, Mussetto A, Laterza L, et al. Diagnosis and management of gastric antral vascular ectasia. WJGE. 2013;5(1):6–13.
   Google Scholar
• Barbara G, De Giorgio R, Salvioli B, et al. Unsuccessful octreotide treatment of the watermelon stomach. J Clin Gastroenterol. 1998;26(4):345–346.
   PubMed Web of Science ®Google Scholar
• McFarlane M, O’Flynn L, Ventre R, et al. Emerging role of thalidomide in the treatment of gastrointestinal bleeding. Front Gastroenterol. 2018;9(2):98–104.
   PubMed Web of Science ®Google Scholar
• Bhowmick BK. Watermelon stomach treated with oral corticosteroid. J R Soc Med. 1993;86(1):52–52.
   PubMed Web of Science ®Google Scholar
• Sherman V, Klassen DR, Feldman LS, et al. Laparoscopic antrectomy: a novel approach to treating watermelon stomach. J Am Coll Surg. 2003;197(5):864–867.
   PubMed Web of Science ®Google Scholar
• Kruger R, Ryan ME, Dickson KB, et al. Diffuse vascular ectasia of the gastric antrum. Am J Gastroenterol. 1987;82(5):421–426.
   PubMed Web of Science ®Google Scholar
• Spahr L, Villeneuve JP, Dufresne MP, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut. 1999;44(5):739–742.
   PubMed Web of Science ®Google Scholar
• Elhendawy M, Mosaad S, Alkhalawany W, et al. Randomized controlled study of endoscopic band ligation and argon plasma coagulation in the treatment of gastric antral and fundal vascular ectasia. United European Gastroenterol J. 2016;4(3):423–428.
   PubMed Web of Science ®Google Scholar
• Mathou NG, Lovat LB, Thorpe SM, et al. Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach. Lasers Med Sci. 2004;18(4):213–218.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Mitsunaga A, Oi I, et al. Long-term follow-up of gastric antral vascular ectasia treated by argon plasma coagulation. Gastrointest Endosc. 2005;61(5):AB177.
   Web of Science ®Google Scholar
• Roman S, Saurin JC, Dumortier J, et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy. 2003;35(12):1024–1028.
   PubMed Web of Science ®Google Scholar
• Farooq FT, Wong RC, Yang P, et al. Gastric outlet obstruction as a complication of argon plasma coagulation for watermelon stomach. Gastrointest Endosc. 2007;65(7):1090–1092.
   PubMed Web of Science ®Google Scholar
• Baudet JS, Salata H, Soler M, et al. Hyperplastic gastric polyps after argon plasma coagulation treatment of gastric antral vascular ectasia (GAVE). Endoscopy. 2007;39(S 1):E320–E320.
   PubMedGoogle Scholar
• Haidry RJ, Dunn JM, Butt MA, et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology. 2013;145(1):87–95.
   PubMed Web of Science ®Google Scholar
• Magee C, Lipman G, Alzoubaidi D, et al. Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia. United European Gastroenterol J. 2019;7(2):217–224.
   PubMed Web of Science ®Google Scholar
• McCarty TR, Rustagi T. Comparative Effectiveness and safety of radiofrequency ablation versus argon plasma coagulation for treatment of gastric antral vascular ectasia: a systematic review and meta-analysis. J Clin Gastroenterol. 2019;53(8):599–606.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Developing NICE guidelines: the manual. London: NICE; 2014.
   Google Scholar
• Jalil A, Ponichtera J, Hameed H, et al. Gastric antral vascular ectasia: clinical features, associations and prognosis. Poster Gut. 2013;62(Suppl 2):A46.2–A47. A1–A50.
   Google Scholar
• Office for National Statistics. National Life Tables, United Kingdom, 1980–82 to 2014–16. 2018.
   Google Scholar
• NHS improvement. National schedule of reference costs 2017–18. 2017.
   Google Scholar
• Personal Social Services Research Unit. Unit Costs of Health and Social Care 2018. London 2018.
   Google Scholar
• NHS Digital. Prescription Cost Analysis – England, 2018. [PAS]. 2018.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). British National Formulary. 2019.
   Google Scholar
• Wilson J, Yao GL, Raftery J, et al. A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Asses. 2007;11(13):1.
   PubMed Web of Science ®Google Scholar
• Boger PC, Turner D, Roderick P, et al. A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett’s oesophagus. Aliment Pharm Ther. 2010;32(11-12):1332–1342.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Barrett’s oesophagus: ablative therapy: Cost Effectiveness Analysis for Barrett’s Oesophagus. Clinical guideline [CG106]. London: NICE; 2010.
   Google Scholar
• van Haalen H, Jackson J, Salehi H, et al. SP333 health state utility of patients with chronic kidney disease and anemia: analysis of EQ-5D in a real world population. Nephrol Dial Transpl. 2018;33(suppl_1):i456–i468.
   Google Scholar
• York Health Economics Consortium. Net Monetary Benefit [online]: York Health Economics Consortium. 2016. [cited 2019 May 9]. Available from: https://www.yhec.co.uk/glossary/net-monetary-benefit/
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. 2013.
   Google Scholar